Konstantin E Voronin

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
557N
67 President St.
Phone843-792-4887
Fax843-792-7353
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Drug Studies, Alcohol, Genetics

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schacht JP, Hoffman M, Voronin KE, Book SW, Anton RF, Schacht JP, Hoffman M, Voronin KE, Book SW, Anton RF. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 10; 47(11):1953-1960. PMID: 35523943; PMCID: PMC9073504.
      Citations:    Fields:    Translation:Humans
    2. Prisciandaro JJ, Hoffman M, Brown TR, Voronin K, Book S, Bristol E, Anton RF, Prisciandaro JJ, Hoffman M, Brown TR, Voronin K, Book S, Bristol E, Anton RF. Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):829-837. PMID: 34256607; PMCID: PMC9161238.
      Citations:    
    3. Anton RF, Voronin KE, Book SW, Latham PK, Randall PK, Glen WB, Hoffman M, Schacht JP, Anton RF, Voronin KE, Book SW, Latham PK, Randall PK, Glen WB, Hoffman M, Schacht JP. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2020 10; 44(10):2084-2096. PMID: 32772383; PMCID: PMC8080431.
      Citations:    
    4. Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E, Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 05 01; 180(5):728-736. PMID: 32150232; PMCID: PMC7063541.
      Citations:    
    5. Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP, Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760. PMID: 29431852; PMCID: PMC5880727.
      Citations:    
    6. Schacht JP, Voronin KE, Randall PK, Anton RF, Schacht JP, Voronin KE, Randall PK, Anton RF. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology. 2018 05; 43(6):1247-1256. PMID: 29362512; PMCID: PMC5916367.
      Citations:    
    7. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF, Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 12; 42(13):2654. PMID: 29123234; PMCID: PMC5686493.
      Citations:    
    8. Anton RF, Schacht JP, Voronin KE, Randall PK, Anton RF, Schacht JP, Voronin KE, Randall PK. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcohol Clin Exp Res. 2017 Jul; 41(7):1370-1380. PMID: 28493623; PMCID: PMC5504690.
      Citations:    
    9. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF, Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653. PMID: 28409564; PMCID: PMC5686497.
      Citations:    
    10. Boyd SJ, Schacht JP, Prisciandaro JJ, Voronin K, Anton RF, Boyd SJ, Schacht JP, Prisciandaro JJ, Voronin K, Anton RF. Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals. Alcohol Alcohol. 2016 Sep; 51(5):549-54. PMID: 27117237; PMCID: PMC5004744.
      Citations:    
    11. Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H, Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22. PMID: 23032071; PMCID: PMC3547192.
      Citations:    
    12. Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF, Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72. PMID: 20571434; PMCID: PMC3595185.
      Citations:    
    13. Voronin K, Randall P, Myrick H, Anton R, Voronin K, Randall P, Myrick H, Anton R. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res. 2008 Nov; 32(11):1954-61. PMID: 18782344; PMCID: PMC2588475.
      Citations:    
    14. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K, Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75. PMID: 18391135; PMCID: PMC2504413.
      Citations:    
    15. Baros AM, Latham PK, Moak DH, Voronin K, Anton RF, Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res. 2007 Apr; 31(4):596-603. PMID: 17374038.
      Citations:    
    16. Myrick H, Anton R, Voronin K, Wang W, Henderson S, Myrick H, Anton R, Voronin K, Wang W, Henderson S. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7. PMID: 17250613.
      Citations:    
    17. Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R, Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005 Aug; 25(4):349-57. PMID: 16012278.
      Citations:    
    18. Drobes DJ, Anton RF, Thomas SE, Voronin K, Drobes DJ, Anton RF, Thomas SE, Voronin K. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin Exp Res. 2004 Sep; 28(9):1362-70. PMID: 15365307.
      Citations:    
    19. Thomas SE, Drobes DJ, Voronin K, Anton RF, Thomas SE, Drobes DJ, Voronin K, Anton RF. Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers. J Stud Alcohol. 2004 May; 65(3):330-5. PMID: 15222589.
      Citations:    
    20. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS, Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology. 2004 Feb; 29(2):393-402. PMID: 14679386.
      Citations: 192     Fields:    Translation:HumansCTClinical Trials
    21. Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D, Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl). 2004 Apr; 173(1-2):32-40. PMID: 14722705.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    22. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R, Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol. 2003 Dec; 23(6):553-62. PMID: 14624185.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    23. Drobes DJ, Anton RF, Thomas SE, Voronin K, Drobes DJ, Anton RF, Thomas SE, Voronin K. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology. 2003 Apr; 28(4):755-64. PMID: 12655322.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    24. Krapivin SV, Bogdanov NN, Voronin KE, Krapivin SV, Bogdanov NN, Voronin KE. [Neurophysiological analysis of the correction by nootropic substances of disorders in the bioelectric activity of the brain in animals during chronic administration of ethanol]. Biull Eksp Biol Med. 1988 Jul; 106(7):52-6. PMID: 3401579.
      Citations:    Fields:    Translation:Animals
    25. Voronina TA, Garibova TL, Sopyev ZhA, Voronin KE, Voronina TA, Garibova TL, Sopyev ZhA, Voronin KE. [Psychotropic properties of nootropic substances with a cholinergic action component in single and long-term use]. Farmakol Toksikol. 1987 Sep-Oct; 50(5):12-5. PMID: 3121384.
      Citations:    Fields:    Translation:Animals
    26. Vrublevskii AG, Voronin KE, Vrublevskii AG, Voronin KE. [Dissociative state in rats induced by ethanol and possibilities of the pharmacological correction of this phenomenon]. Biull Eksp Biol Med. 1987 Aug; 104(8):187-9. PMID: 3620678.
      Citations:    Fields:    Translation:Animals
    27. Rakhmankulova IKh, Garibova TL, Voronin KE, Tilekeeva UM, Voronina TA, Rakhmankulova IKh, Garibova TL, Voronin KE, Tilekeeva UM, Voronina TA. [Effects of piracetam during prolonged use in an experiment]. Farmakol Toksikol. 1985 Jul-Aug; 48(4):42-6. PMID: 4043362.
      Citations:    Fields:    Translation:Animals
    28. Garibova TL, Voronin KE, Rudenko GM, Garibova TL, Voronin KE, Rudenko GM. [Role of cholinergic systems in the formation of a dissociated state in response to kleregil]. Biull Eksp Biol Med. 1984 Nov; 98(11):570-2. PMID: 6542433.
      Citations:    Fields:    Translation:HumansAnimals
    Voronin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (150)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _